Bleeding Disorders in Congenital Syndromes

Susmita N Sarangi1, Suchitra S Acharya2

  • 1Bleeding Disorders and Thrombosis Program, Cohen Children's Medical Center of New York, New Hyde Park, New York.

Pediatrics
|January 8, 2017
PubMed

Insights

Children with rare congenital syndromes may face significant bleeding risks, often undetected. This review guides pediatricians in identifying and managing these risks through a primary care approach.

Area of Science:

  • Pediatric Hematology
  • Genetics and Rare Diseases
  • Clinical Pediatrics

Background:

  • Children with congenital syndromes frequently require complex, multidisciplinary care.
  • Certain syndromes present risks of bleeding due to associated hematologic (e.g., thrombocytopenia, platelet disorders, factor deficiencies) and vascular abnormalities.
  • Bleeding risk is often subtle and poorly documented, complicating care for pediatricians managing these rare conditions.

Purpose of the Study:

  • To review the etiology of bleeding in various congenital syndromes.
  • To outline hematologic and nonhematologic clinical manifestations associated with bleeding risks.
  • To emphasize the importance and timing of diagnostic evaluations for identifying bleeding risks in a primary care setting.

Main Methods:

  • Literature review focusing on congenital syndromes associated with bleeding risks.
  • Synthesis of information on the etiology and clinical manifestations of bleeding.
  • Discussion of diagnostic strategies and primary care management.

Main Results:

  • Identified specific congenital syndromes linked to increased bleeding potential.
  • Detailed hematologic and nonhematologic signs indicative of bleeding risk.
  • Highlighted the necessity for proactive diagnostic assessment in primary care.

Conclusions:

  • Pediatricians play a crucial role in managing bleeding risks in children with congenital syndromes.
  • Early and thorough diagnostic evaluation is essential for uncovering often-unrecognized bleeding tendencies.
  • A primary care-centered approach can effectively mitigate bleeding complications in affected children.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.2K
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.3K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.4K